Work

Recent trends in US real-world first-line (1L) treatment patterns for patients with locally advanced or metastatic urothelial carcinoma (la/mUC).

Year: 2025

Type: conference-abstract

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16556

Authors: Guru P. Sonpavde, Lisa Mucha, Candice Willmon, Christina Marie Quicquaro, Shengqian Li, Anran Tan, Allison Thompson, Vanessa Shih, Alicia K. Morgans

Institutions: University of Central Florida, AdventHealth, Astellas Pharma (United States), Pfizer (United States), Dana-Farber Cancer Institute

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Pfizer

OpenAlex ID: W4410816987

Cites:

Cited by:

Related to: 10